UBS AM’s Starling Oncology STLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$8K Hold
1,265
– – ﹤0.01% 3840

Other funds holding STLN

UBS AM's STLN Position: Q3 2026 in Review

UBS AM reported 1,265 shares of Starling Oncology (STLN) worth $8K in Q3 2026. The position accounts for ﹤0.01% of the portfolio, ranked #3840.

131 funds tracked by Wall St. Rank hold STLN as of Q3 2026.

  • UBS AM held 1,265 shares of Starling Oncology worth $8K as of Q3 2026.
  • Starling Oncology made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #3840 holding.
  • 131 funds tracked by Wall St. Rank held Starling Oncology as of Q3 2026.

Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.